November 19, 2015

Nutrition21 Announces The Settlement Of A Patent Infringement Lawsuit Concerning Chromium Picolinate

JDS Therapeutics, LLC and Nutrition 21, LLC (“Nutrition 21”) announced that they have entered into a confidential settlement and license agreement with CVS Pharmacy, Inc. (“CVS”).  The settlement ends a patent infringement lawsuit brought by Nutrition 21 against CVS in the Southern District of New York related to

more news

MORE NEWS
Get in Touch

250 Pehle AvenueSuite 200Saddle Brook, NJ 07663

Nutrition21 Proudly Supports the Following Industry Associations

footer 2023 uai Nutrition21

©2023 Nutrition21, LLC. All rights reserved.       

Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC.  All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.